Insights

Best Longevity Clinics in Dubai and the UAE (2026): The Atlas View

2026 ·12 minute read · By Sumesh Peringeth

In short

The UAE now has one of the densest clusters of longevity and preventive clinics in the world, and Abu Dhabi is the first jurisdiction anywhere to license healthy longevity medicine as a regulated category. This guide maps the field from the Healthspan Economy Atlas rather than a shortlist, separates the testing that has evidence behind it from the interventions that run ahead of the science and cites regulators and the clinics themselves for every claim. We record. We do not recommend.

Most guides to longevity clinics in Dubai compare four or five venues the author has chosen. This one starts from a count. Knowing how many clinics exist, where they are and what a regulator has actually verified is the difference between a citable map and a curated opinion.

Healthspan Economy is a neutral map, not a judge. Ordering below follows geography and evidence posture, not our ranking or anyone’s sponsorship.

How many longevity clinics are there in Dubai and the UAE?

The Healthspan Economy Atlas records 48 UAE organizations that are operating as of July 2026 across every health category. Of those, 26 genuinely deliver longevity, preventive or advanced-screening services directly to individuals, that is longevity medicine, preventive medicine, executive or advanced health screening or preventive-risk diagnostics.¹ The other 22 sit in the Atlas on their own merits, that is fertility clinics, general telehealth platforms and reference laboratories, but they are not longevity or preventive providers and this guide does not count them as such. Of the 26 longevity and preventive providers, 22 have a presence in Dubai and 5 have a presence in Abu Dhabi, with DNA Health & Wellness operating in both, so the emirate figures sum to more than the total.² Two further longevity venues, SHA Emirates Island in Abu Dhabi and Six Senses The Palm in Dubai, are announced but not yet open and are left out of a present-tense count, and two more, Longevity Wellness Hub and Valeo Health, are recorded as defunct and likewise excluded. The inclusion test is deliberately strict: the organization must deliver a preventive or longevity health service to individuals, not merely exist in the health sector, sell a product or book other people’s clinics.³

That number is the point of this guide. A directory that tracks four UAE clinics can rank them. It cannot tell you what the market looks like. Dubai holds the clear majority of UAE longevity provision, Abu Dhabi holds a smaller but more heavily regulated cluster and the rest of the country is thin. Any guide that presents three or four Dubai venues as “the UAE longevity scene” is describing its own reading list, not the field.

Choose the Atlas view if you want to understand the whole market before you shortlist. It is less useful if you have already decided on a single clinic and only want a booking link.

This guide is the judgment layer: the evidence tiers, the regulatory picture and what to ask before booking. For the structured record, the running count, the four-pillar breakdown and every mapped organization, see the Atlas country page for the United Arab Emirates. That page counts on the Atlas’s broader Moderate scope, which holds out only fertility clinics and pure booking or telehealth platforms, so its UAE figure is higher than the strict longevity-and-preventive figure this guide leads on. The two are different lenses on the same field, not two attempts at the same list.

What does the UAE actually regulate in longevity medicine?

The most developed regulatory fact about longevity medicine in the UAE sits in Abu Dhabi. On October 31, 2024, the Department of Health Abu Dhabi, the regulator of the emirate’s healthcare sector, introduced a licensing framework to establish Healthy Longevity Medicine Centres, which it described as the first initiative of its kind globally.⁴⁵ The department published a written standard, the Healthy Longevity Medicine Clinic Standard, with a publication date of October 2024 and an effective date of April 2025.⁶ That standard is specific rather than aspirational: it sets patient eligibility, requires a multidisciplinary team including physicians with at least five years of relevant experience or formal training in longevity and lifestyle medicine, mandates evidence-based clinical guidelines and informed consent and defines the diagnostic and intervention menu a licensed center may offer.⁶

Dubai is now building its own regime, and it went further than a single facility standard. On June 10, 2026, Sheikh Mohammed bin Rashid Al Maktoum issued Law No. 17 of 2026 establishing the Dubai Longevity Authority, a dedicated regulator mandated to create a science-driven, risk-proportionate framework and to license and supervise the entire value chain, from research and clinical trials through manufacturing, delivery and patient clinics.⁷ The authority was created in coordination with the Dubai Health Authority and other Dubai bodies, and it is new, so as of July 2026 it is standing up its licensing regime rather than issuing longevity-clinic licenses at scale.⁷ The accurate statement for a buyer today is that Abu Dhabi already licenses Healthy Longevity Medicine Centres against a published standard, while Dubai has just created the authority that will license them and has not yet built out the equivalent clinic license.

Dubai does, separately, already bind one high-risk part of the market. The Dubai Health Authority’s Standards for Stem Cells and Regenerative Medicine, effective April 20, 2025, govern any stem cell or regenerative service delivered in a DHA-licensed facility.⁸ That standard is procedure-specific rather than a longevity-clinic license, and its substance sits in the evidence section below.

This matters for buyers because Abu Dhabi already offers a verifiable floor and Dubai does not yet. In Abu Dhabi, a facility that holds the Healthy Longevity Medicine Centre license has been assessed against a written government standard for that specific category. In Dubai, “longevity clinic” remains a term any licensed medical facility can adopt until the Dubai Longevity Authority’s clinic-licensing regime is in force, so a Dubai clinic’s longevity credibility rests for now on its general facility license, its compliance with the DHA regenerative-medicine standard where that applies and its own stated methods.

The self-assigned longevity label is the failure mode Dubai’s regulatory gap makes possible. Until the Dubai Longevity Authority’s clinic license is live, any licensed medical facility can call itself a longevity clinic, and the word carries no verified floor. In Abu Dhabi the license means a government standard was met. In Dubai, for now, it means the clinic chose the word.

Choose an Abu Dhabi licensed centre if regulatory verification of the longevity category itself is what you want today. A Dubai clinic can be excellent, but its longevity designation is self-assigned until the Dubai Longevity Authority’s licensing is live, so the burden shifts to you to check who interprets your results and what evidence stands behind each service.

Which UAE clinics hold the healthy longevity medicine license?

Two facilities anchor Abu Dhabi’s regulated cluster, and both are verifiable through the regulator rather than through their own marketing.

The Institute for Healthier Living Abu Dhabi was licensed by the Department of Health Abu Dhabi on November 19, 2024, as the world’s first specialized healthy longevity medicine centre.⁹ Its own site confirms the designation and displays the Department of Health facility number MF7969.¹⁰ The institute describes three arms: a healthy longevity medicine clinic, an innovation hub and a population health research function, and it presents itself as a precision lifestyle medicine start-up rather than a walk-in clinic, operating a waitlist at the time of writing.¹⁰ Choose the institute if you want the first facility built explicitly to the DoH standard and you are comfortable joining a waitlist. It is less suitable if you need immediate access or a purely cosmetic service.

Pura Longevity Clinic, part of the state-linked PureHealth group, was licensed by the Department of Health Abu Dhabi as a healthy longevity medicine facility and is based at Sheikh Shakhbout Medical City.¹¹ The clinic states it integrates longevity medicine with primary care and offers diagnostic services, a sleep clinic and physical and mental fitness training, alongside a health overview delivered through a roughly 120-minute battery of tests and assessments with a physician.¹¹ Choose Pura if you want a regulated longevity service attached to a large hospital system and primary care. It is less suitable if you specifically want an independent boutique rather than an institutional program.

Where are the Dubai clinics, and what should you verify yourself?

Dubai holds the larger share of UAE longevity provision, and it is more varied. The Atlas records dedicated longevity clinics, hospital longevity units inside international brands, resort and hospitality longevity offerings and diagnostics-led platforms across the city.¹ Because Dubai has no longevity-specific license, the useful question is not “is this clinic ranked” but “what exactly does it deliver, and who stands behind the interpretation.”

One prominent example illustrates why the distinction matters. The Longevity Hub by Clinique La Prairie, inside the One&Only One Za’abeel tower, operates a three-storey, 3,800 square meter space and says it runs the first Longevity Index assessment space in the region.¹² Its own booking system lists both evidence-oriented services, that is nutritional coaching, movement assessment and physiotherapy, and interventions whose evidence status is contested, including exosome therapy, autologous stem cell protocols, platelet-rich plasma, IV drips and ozone therapy.¹² That combination is common across the Dubai market and is the reason the honest question is per service, not per clinic. A single venue can offer a well-supported diagnostic workup and an unproven cell therapy under the same roof.

The resort-spa longevity menu is the failure mode built for the buyer on holiday. A hospitality venue adds a longevity menu to a spa, and the setting does the persuading that the evidence cannot. Ask who interprets the results and what license the facility holds. If the answer is a therapist and a spa license, it is a spa.

Verify three things for any Dubai clinic before booking: the specific license the facility holds, the name and specialty of the physician who will interpret your results and whether each service you are paying for is a diagnostic, a lifestyle intervention or an experimental biologic. The Atlas can tell you a clinic exists and what category it sits in. It cannot substitute for reading the clinic’s own consent and service documents.

What is the evidence behind what these clinics sell?

The house position is old practices, honest evidence. The most useful way to read any UAE longevity menu is to split it into what is diagnostic and evidence-supported and what is interventional and contested, because a luxury setting changes neither.

Diagnostic and assessment services are the better-supported half of the market. Cardiorespiratory fitness testing such as VO2 max, body composition by DEXA, advanced blood biomarker panels including ApoB and markers of glucose regulation and structured sleep and cognitive assessment are established clinical tools that can surface real, actionable risk. The honest caveat is not that the tests are fake but that more testing produces more incidental findings and false positives, and that some newer measures, notably epigenetic biological-age clocks, still vary between labs and should be read as a signal to discuss with a physician rather than a verdict. Choose a diagnostics-led program if your goal is early detection and a baseline you can act on. It is less suitable if you expect a single number to settle your health status.

Interventional services marketed for longevity are where the evidence thins and, in some cases, disappears. This is where a buyer needs the regulators directly.

On stem cell and related regenerative products, the US Food and Drug Administration states that the only stem cell products it has approved consist of blood-forming stem cells derived from umbilical cord blood, approved for disorders affecting blood production and not for other uses.¹³ The FDA further states that there are no approved exosome products, and that products derived from adipose tissue, that is stromal vascular fraction, along with umbilical cord blood, Wharton’s jelly and amniotic fluid, have not been approved to treat orthopedic, neurological, cardiovascular or other conditions for which they are commonly marketed.¹³ In a separate public safety alert, the FDA documented serious adverse events, including reports of blindness, tumor formation and infection linked to unapproved products marketed as stem cell or exosome therapies, and warned that treatments delivered in countries that do not require regulatory review may make it hard to know whether an experimental treatment is reasonably safe.¹⁴

The International Society for Stem Cell Research, the field’s main professional body, states the position more plainly still. It says there are very few conditions for which stem cell therapies are proven and widely accepted, primarily blood stem cell transplantation for diseases of the blood such as leukemia and sickle cell anemia, and that treatments for most other conditions remain experimental and have not been shown to be safe and effective.¹⁵ The society warns that patients undergoing unproven treatments take on physical and financial risk even when the treatment uses their own cells, and that being charged to receive a treatment is itself a warning sign.¹⁵

The UAE’s own regulators draw the same line, which is what keeps this from being an American caution imported into a Gulf market. The Dubai Health Authority’s Standards for Stem Cells and Regenerative Medicine, effective April 20, 2025, bind every stem cell and regenerative service delivered in a DHA-licensed facility, require informed consent from donors and recipients, demand that marketing materials be factual and clear and name the risks of unregulated stem cell clinics directly: misleading advertising that targets vulnerable patients, a lack of scientific evidence supporting therapeutic claims and an absence of long-term safety data.⁸ Abu Dhabi’s Healthy Longevity Medicine Clinic Standard goes further and rates specific services. Its diagnostic appendix places telomere length, senescent-cell markers and liquid biopsies in a tier it labels not recommended outside a research protocol, and its intervention appendix reserves its applicable rating for lifestyle measures and approved-use drugs while assigning IV stem cell infusions, exosome treatment, gene therapy, IV nutrient infusions, plasmapheresis and hyperbaric oxygen to its cautionary tiers, that is either clinic discretion or not currently applicable and needing further data.⁶ A UAE buyer can therefore check a marketed longevity intervention against the emirate’s own standard, not only against the FDA.

Peptide therapy, NAD+ and other IV nutrient infusions, hyperbaric oxygen, cryotherapy and hormone optimization occupy a similar contested band. Some have defined, narrow medical uses and none should be read as a validated way to extend healthy lifespan on current evidence. Choose an interventional service only after a physician who knows your history has explained the specific evidence and the regulatory status, and treat any clinic that cannot produce that explanation as a reason to walk.

The unlicensed regenerative offer is the clearest failure mode in this market. A clinic markets stem cell, exosome or stromal vascular fraction therapy as a longevity treatment, and no regulator has approved any of it for that use. The FDA, the ISSCR and the UAE’s own Dubai and Abu Dhabi standards all place these interventions outside the approved set for longevity. A price tag and a consent form do not change that.

State the rule simply. If a UAE clinic offers stem cell, exosome, stromal vascular fraction, peptide or IV-heavy protocols for longevity, the correct posture is caution, the correct question is “what regulator has approved this for this use,” and on current evidence, whether you ask the FDA, the ISSCR or the UAE’s own Dubai and Abu Dhabi standards, the answer for longevity indications is that none has.

How should you choose a longevity clinic in Dubai or the UAE?

Match the clinic to a goal, and match the goal to the evidence. If you want regulatory verification of the longevity category, an Abu Dhabi healthy longevity medicine centre is the only option that clears that specific bar today.⁴ If you want a diagnostics-led baseline and early detection, prioritize clinics that are explicit about who interprets results and that schedule follow-up, and weight established tests over novel biological-age scores. If a clinic’s pitch centers on regenerative injections, cell therapies or infusions marketed as longevity treatments, the FDA and ISSCR positions above are the frame to carry into the consultation, and the burden is on the clinic to show approval and evidence for the specific use.

The one caution that ties the whole market together is that the strongest, cheapest, least photogenic interventions still win on evidence: physical activity, nutrition, sleep, vaccination and detecting disease early. A premium UAE clinic earns its price when it helps you do those with precision. It does not earn it by selling a shortcut around them.

Cite this article: Healthspan Economy, “Best Longevity Clinics in Dubai and the UAE (2026): The Atlas View,” healthspaneconomy.com. Free to cite with attribution.

Healthspan Economy Atlas, Entities_Public dataset, counts computed July 26, 2026. Internal dataset of record; figures are attributable to Healthspan Economy. ↩ ↩²
Per-row classification for the longevity-provider figure is recorded against Entities_Public, so the count is auditable. Total operating rows 48, of which 26 pass the longevity, preventive or screening test, 2 are announced but not yet open and 2 are defunct. The figure reflects the July 2026 deduplication of the two Biongevity rows into one. ↩
Healthspan Economy, Atlas inclusion policy (ATLAS_POLICY.md), scope bar requiring delivery of a health service to individuals. Internal, July 2026. ↩
Department of Health Abu Dhabi, “Abu Dhabi sets standards for the world’s first Healthy Longevity Medicine Centres,” October 31, 2024. https://www.doh.gov.ae/en/news/abu-dhabi-sets-standards-for-the-world-first-healthy-longevity-medicine-centres ↩ ↩²
Abu Dhabi Media Office, “Department of Health - Abu Dhabi implements framework to establish Healthy Longevity Medicine Centres in the emirate,” October 31, 2024. https://www.mediaoffice.abudhabi/en/health/department-of-health-abu-dhabi-implements-framework-to-establish-healthy-longevity-medicine-centres-in-the-emirate/ ↩
Department of Health Abu Dhabi, “Healthy Longevity Medicine Clinic Standard,” Document Ref. DOH/SD/HLMCS/HCF/V1/2024, publication date October 2024, effective date April 2025. Primary PDF confirms the effective date, the multidisciplinary staffing and eligibility requirements and the diagnostic and intervention appendices cited here (including the “not recommended outside of research protocol” diagnostic tier and the intervention rating scale). https://www.doh.gov.ae/-/media/DOH/StanddardOfLogeivity.ashx ↩ ↩² ↩³
Government of Dubai Media Office, “Mohammed bin Rashid issues law establishing Dubai Longevity Authority,” June 10, 2026. Law No. 17 of 2026 establishes the Dubai Longevity Authority, mandated to build a science-driven, risk-proportionate framework and to license and supervise the value chain from research and clinical trials to patient clinics, in coordination with the Dubai Health Authority and other Dubai bodies. https://mediaoffice.ae/en/news/2026/jun/10-06/mohammed-bin-rashid-issues-law-establishing-dubai-longevity-authority ↩ ↩²
Dubai Health Authority, “Standards for Stem Cells and Regenerative Medicine,” Version 1, Code DHA/HRS/HPSD/ST-68, issue date February 20, 2025, effective date April 20, 2025. Scope covers stem cell and regenerative medicine services in DHA-licensed health facilities; requires informed consent from donors and recipients and factual marketing materials (section 8.7.3); section 12.2.4 names the risks of unregulated stem cell clinics (misleading advertising targeting vulnerable patients, lack of scientific evidence for therapeutic claims, absence of long-term safety data). https://www.dha.gov.ae/uploads/022025/Standards%20for%20Stem%20Cells%20and%20Regenerative%20Medicine202522994.pdf ↩ ↩²
Department of Health Abu Dhabi, “Department of Health - Abu Dhabi licenses Institute for Healthier Living Abu Dhabi as the world’s first specialised Healthy Longevity Medicine Centre,” November 19, 2024. https://www.doh.gov.ae/en/news/doh-licenses-institute-for-healthier-living-ad-longevity-medicine-centre ↩
Institute for Healthier Living Abu Dhabi, official site, homepage and footer stating “world’s first licensed Healthy Longevity Medicine Centre” and DoH facility number MF7969. Accessed July 26, 2026. https://www.ihlad.ae/ ↩ ↩²
PureHealth, “Department of Health - Abu Dhabi licenses Pura Longevity Clinic as PureHealth’s leading longevity science facility,” published January 30, 2025, sourced to Abu Dhabi Media Office. Accessed July 26, 2026. https://purehealth.ae/department-of-health-abu-dhabi-licenses-pura-longevity-clinic-as-purehealths-leading-longevity-science-facility/ ↩ ↩²
Longevity Hub by Clinique La Prairie, Dubai (One Za’abeel Polyclinic), official site, homepage and booking service list. Accessed July 26, 2026. https://longevity-hub.cliniquelaprairie.com/dubai/ ↩ ↩²
US Food and Drug Administration, “Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes,” dated July 22, 2020, content current as of April 9, 2024. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes ↩ ↩²
US Food and Drug Administration, “Public Safety Alert Due to Marketing of Unapproved Stem Cell and Exosome Products,” posted December 9, 2019. https://www.fda.gov/safety/medical-product-safety-information/public-safety-alert-due-marketing-unapproved-stem-cell-and-exosome-products ↩
International Society for Stem Cell Research, About Stem Cells, “Unproven Stem Cell ‘Treatments’.” Accessed July 26, 2026. https://www.aboutstemcells.org/info/unproven-treatments ↩ ↩²

Related insights

Best Healthspan Clinics in Singapore, According to Reddit (2026)
Singapore's most-discussed longevity and preventive-health clinics, ordered by community attention rather than our own ranking, with honest notes on cost, evidence, and what is still unproven.
How AI search actually decides which clinic to cite
AI search is not a black box so much as a system with observable rules. It retrieves sources, weighs their authority and cites a few. Knowing how that works explains why some clinics are cited constantly and others never appear.
The Gulf is becoming the axis of the longevity economy
Abu Dhabi wrote the first rulebook for longevity medicine. Riyadh is funding the science at a scale no one else matches. The premium clinics are following. For Western operators, the question has shifted from whether to engage the Gulf to how.
Why premium longevity clinics are invisible in AI search
In a study of 25 leading longevity clinics, three returned no results at all across four AI platforms and 200 query-platform observations. All three were premium-priced and well-regarded at home. Their disappearance is a warning about how AI search now decides who exists.

Questions

Frequently asked questions

How many longevity clinics are in Dubai and the UAE?

The Healthspan Economy Atlas records 48 UAE organizations operating across all health categories as of July 2026. Of those, 26 genuinely deliver longevity, preventive or advanced-screening services to individuals, with 22 present in Dubai and 5 in Abu Dhabi (DNA Health & Wellness operates in both, so the emirate figures sum to more than the total). The remaining 22 are fertility clinics, general telehealth platforms and reference laboratories that belong in the Atlas but are not longevity or preventive providers. Two more longevity venues are announced but not yet open, and two are defunct, so neither group is counted.

Is there a government license specifically for longevity clinics in the UAE?

Yes, in Abu Dhabi, and Dubai is building one. The Department of Health Abu Dhabi introduced a Healthy Longevity Medicine Centre licensing framework on October 31, 2024, described as the first of its kind globally, with a written clinic standard published in October 2024 and effective April 2025. Dubai created a dedicated regulator, the Dubai Longevity Authority, by Law No. 17 of 2026 on June 10, 2026, mandated to license longevity clinics, trials and therapies, but the authority is new and its clinic-licensing regime is still being stood up. Dubai also enforces a separate stem cell and regenerative-medicine standard through the Dubai Health Authority, effective April 20, 2025.

Which UAE clinics are actually licensed as longevity centres?

The Institute for Healthier Living Abu Dhabi was licensed as the world's first specialized healthy longevity medicine centre on November 19, 2024, and displays Department of Health facility number MF7969. Pura Longevity Clinic, at Sheikh Shakhbout Medical City, was subsequently licensed under the same framework.

Do longevity clinics in Dubai offer stem cell and exosome treatments, and do they work?

Some do, often alongside legitimate diagnostics. The FDA states there are no approved exosome products and that the only approved stem cell products are cord-blood-derived and only for blood disorders. The ISSCR states that stem cell therapies are proven for very few conditions, mainly blood diseases, and that most other uses are experimental. The UAE's own regulators agree: the Dubai Health Authority's regenerative-medicine standard flags the risks of unregulated stem cell clinics, and Abu Dhabi's longevity clinic standard places IV stem cell infusions and exosome treatment in its cautionary rather than applicable tier. For longevity indications specifically, no regulator has approved these treatments.

Are the scans and biomarker panels worth it?

They can be. Established tests such as VO2 max, DEXA and advanced blood panels can catch real problems early. The trade-off is more false positives and incidental findings, and newer biological-age clocks still vary between labs, so any single number is a prompt to talk to a physician, not a diagnosis.

Does the UAE regulate the interventions themselves?

Partly, and increasingly. The Abu Dhabi framework licenses the facility category and, through its clinic standard, rates specific diagnostics and interventions by evidence tier. The Dubai Health Authority separately regulates stem cell and regenerative services through a binding standard. Neither converts an individually unproven intervention into a validated one. A licensed center is a verified venue, not a guarantee that every service on its menu has regulatory approval for a longevity use.